Today’s topic: Meningococcal vaccine
Action requested: Be aware of guidance to support provider recommendations to patients about meningococcal B vaccine.
Background & Recommendations: In October 2015, the Advisory Committee on Immunization Practice (ACIP) recommended meningococcal B vaccine for patients at high risk for this disease and for outbreak control, but left it to providers’ discretion whether or not to recommend the vaccine for other patients (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6441a3.htm). This recommendation differs from the ACIP recommendation for meningococcal conjugate ACYW vaccine (MCV4), which is recommended for all persons 11 through 18 years of age (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm). The Washington State Department of Health has issued guidance to help providers manage use of the meningococcal B vaccine, including recommended language when talking with parents of children who are not at high risk. See http://www.doh.wa.gov/Portals/1/Documents/Pubs/348-NonDOH-ClinicalGuidanceMeningococcalBVaccine.pdf.
You can find my recent health alerts posted on the Provider pages of our website, at http://www.snohd.org/Providers/Health-Alerts.